Table 5.
68Ga labeled radiopharmaceuticals substituting 18F, 11C labeled compounds
| Diagnostics modality | Established 11C/18F labeled agents | Potential 68Ga labeled agents |
|---|---|---|
| Angiogenesis | 18F-galacto-RGD | 68Ga-DOTA-RGD, 68Ga-VEGF |
| General cancer imaging | 18FDG | 68Ga-CXCR4 biomarker, 68Ga-uPAR biomarker, 68Ga-SCN-NOTA-BZA |
| Hypoxia | 18F-nitroimidazloes (FAZA, FMISO, FETNIM) | 68Ga-DOTA-imidazoles |
| Proliferation | 18FLT | 68Ga-DO3A-thymidine |
| Glioma | 18FET, 11C-methionine | 68Ga-glutamine, 68Ga-DO3A-alanine, 68Ga-DO2A-tyrosine |
| Prostate cancer | 18FDG, 11C-acetate, 18F-choline, 11C-choline | 68Ga-DOTA-PSMA |